Ramkumar Mandalam
Direktor/Vorstandsmitglied bei CRYOPORT, INC.
Vermögen: 576 009 $ am 31.05.2024
Aktive Positionen von Ramkumar Mandalam
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CRYOPORT, INC. | Direktor/Vorstandsmitglied | 16.06.2014 | - |
| Independent Dir/Board Member | 16.06.2014 | - | |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Direktor/Vorstandsmitglied | 20.10.2010 | - |
| Vorstandsvorsitzender | 01.01.2005 | - | |
| Präsident | 01.01.2005 | - | |
Stempeutics Research Pvt. Ltd.
 Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Direktor/Vorstandsmitglied | - | - |
| Citra Bioconsulting, Inc. | Vorstandsvorsitzender | 01.01.2021 | - |
| Gründer | 01.01.2021 | - |
Karriereverlauf von Ramkumar Mandalam
Ehemalige bekannte Positionen von Ramkumar Mandalam
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VERICEL CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1994 | 01.01.2000 |
| Corporate Officer/Principal | 01.01.1994 | 01.01.2000 | |
| GERON CORPORATION | Corporate Officer/Principal | - | - |
Ausbildung von Ramkumar Mandalam
| University of Michigan | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Indien | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Transportation | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GERON CORPORATION | Health Technology |
| VERICEL CORPORATION | Health Technology |
| CRYOPORT, INC. | Transportation |
| Private Unternehmen | 3 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Stempeutics Research Pvt. Ltd.
Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Health Technology |
| Citra Bioconsulting, Inc. |
- Börse
- Insiders
- Ramkumar Mandalam
- Erfahrung
